作者：
Yap,Y.S. [1]
;
Cornelio,G.H. [2]
;
Devi,B.C.R. [3]
;
Khorprasert,C. [4]
;
Kim,S.B. [5]
;
Kim,T.Y. [6]
;
Lee,S.C. [7]
;
Park,Y.H. [8]
;
Sohn,J.H. [9]
;
Sutandyo,N. [10]
;
Wong,D.W.Y. [11]
;
Kobayashi,M. [12]
;
Landis,S.H. [13]
;
Yeoh,E.M. [14]
;
Moon,H. [15]
;
Ro,J. [16]
作者单位：
Department of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, Singapore
[1]
GlaxoSmithKline (China) R and D Co. Ltd., 917 Halei Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai
[2]
Department of Radiotherapy, Oncology and Palliative Care, Sarawak General Hospital, Kuching 93586
[3]
National Cancer Center, 111 Jeongbalsanro, Ilsan-gu, Goyang-si, Gyeonggi-do 410-769, South Korea
[4]
Samsung Medical Center, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, South Korea
[5]
Severance Hospital, Yonsei University Health System, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752
[6]
Saint Peregrine Oncology Unit, San Juan de Dios Hospital, 2772 Roxas Boulevard, Pasay City 1300
[7]
European Medical Affairs, GlaxoSmithKline, 1-3 Iron Bridge Road, Uxbridge, Middlesex UB11 1BT
[8]
Department of Haematology-Oncology, National University Health System, 1E Kent Ridge Road
[9]
Division of Radiation Oncology, Faculty of Medicine, Chulalongkorn University, Rama 4 Road, Bangkok
[10]
GlaxoSmithKline, 5 Moore Drive 17.2136K.2A, Research Triangle Park, NC 27709, United States
[11]
Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia
[12]
Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu
[13]
Oncology R and D, GlaxoSmithKline Pte Ltd., 150 Beach Road Gateway West, Singapore 189720, Singapore
[14]
Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, South Korea
[15]
Dharmais Hospital National Cancer Center, Jl. Let. Jend. S. Parman Kav. 84-86, Slipi, Jakarta Barat
[16]
发布时间
2013-11-20
换一批
